Cortés JA - Search Results

1

[Effect of adequate initial antimicrobial therapy on mortality in critical patients with Pseudomonas aeruginosa bacteremia].

González AL, Leal AL, Cortés JA, Sánchez R, Barrero LI, Castillo JS, Álvarez CA. González AL, et al. Among authors: cortes ja. Biomedica. 2014 Apr;34 Suppl 1:58-66. doi: 10.1590/S0120-41572014000500008. Biomedica. 2014. PMID: 24968037 Spanish.

2

[Anti-microbial resistance in intensive care units in Bogotá, Colombia, 2001-2003].

Alvarez C, Cortes J, Arango A, Correa C, Leal A; Grupo para el Control de la Resistencia Bacteriana en Bogotá. Alvarez C, et al. Rev Salud Publica (Bogota). 2006 May;8 Suppl 1:86-101. doi: 10.1590/s0124-00642006000400008. Rev Salud Publica (Bogota). 2006. PMID: 16925124 Free article. Spanish.

3

[Therapeutic approach to Staphylococcus aureus bacteremia].

Tibavizco D, Rodríguez JY, Silva E, Cuervo SI, Cortés JA. Tibavizco D, et al. Among authors: cortes ja. Biomedica. 2007 Jun;27(2):294-307. Epub 2007 Aug 21. Biomedica. 2007. PMID: 17713640 Review. Spanish.

4

[Community-acquired methicillin-resistant Staphylococcus aureus in Bogotá, Colombia: Public Health implications].

Cortes JA, Gómez CA, Cuervo SI, Leal AL; GREBO. Cortes JA, et al. Rev Salud Publica (Bogota). 2007 Jul-Sep;9(3):448-54. doi: 10.1590/s0124-00642007000300013. Rev Salud Publica (Bogota). 2007. PMID: 18026609 Free article. Spanish.

5

Identifying and controlling a multiresistant Pseudomonas aeruginosa outbreak in a Latin-American cancer centre and its associated risk factors.

Cortes JA, Cuervo SI, Urdaneta AM, Potdevin G, Arroyo P, Bermúdez D, Correa A, Villegas MV. Cortes JA, et al. Braz J Infect Dis. 2009 Apr;13(2):99-103. doi: 10.1590/s1413-86702009000200005. Braz J Infect Dis. 2009. PMID: 20140351

6

Risk factors for mortality caused by Staphylococcus aureus bacteremia in cancer patients.

Cuervo SI, Cortés JA, Sánchez R, Rodríguez JY, Silva E, Tibavizco D, Arroyo P. Cuervo SI, et al. Among authors: cortes ja. Enferm Infecc Microbiol Clin. 2010 Jun-Jul;28(6):349-54. doi: 10.1016/j.eimc.2009.06.015. Epub 2010 Apr 28. Enferm Infecc Microbiol Clin. 2010. PMID: 20430483

7

Differences in determining in vitro tigecycline susceptibility according to the agar medium used.

Leal AL, Buitrago G, Ovalle MV, Cortés JA, Alvarez CA, Larrota J; Colombian Tigecycline Susceptibility Surveillance Group. Leal AL, et al. Among authors: cortes ja. J Chemother. 2010 Apr;22(2):137-8. doi: 10.1179/joc.2010.22.2.137. J Chemother. 2010. PMID: 20435576 No abstract available.

8

[Left-sided infective endocarditis caused by Pseudomonas aeruginosa treated medically].

Ordóñez KM, Hernández OA, Cortés JA, López MJ, Alfonso G, Junca A. Ordóñez KM, et al. Among authors: cortes ja. Biomedica. 2010 Apr-Jun;30(2):164-9. Biomedica. 2010. PMID: 20890563 Spanish.

9

Comparing in vitro activity of tigecycline by using the disk diffusion test, the manual microdilution method, and the VITEK 2 automated system.

Leal Castro AL, Buitrago Gutierrez G, Ovalle V, Cortes JA, Alvarez CA; Colombian Tigecycline Susceptibility Surveillance Group. Leal Castro AL, et al. Among authors: cortes ja. Rev Argent Microbiol. 2010 Jul-Sep;42(3):208-11. Rev Argent Microbiol. 2010. PMID: 21180392

10

Impact of inappropriate antimicrobial therapy on patients with bacteremia in intensive care units and resistance patterns in Latin America.

Cortés JA, Garzón DC, Navarrete JA, Contreras KM. Cortés JA, et al. Rev Argent Microbiol. 2010 Jul-Sep;42(3):230-4. Rev Argent Microbiol. 2010. PMID: 21180395 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters